Zinc acetate dihydrate

醋酸锌二水合物

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NameZinc acetate dihydrate
Drug Alias NameGalzinWilzinNOBELZINE-650ET-700 +[6] 
ClassificationSmall molecules
Mechanisms of ActionCopper absorption inhibitor
TargetsNot applicable
Therapy Area/IndicationsHypozincemiaInfantile Epileptic-Dyskinetic EncephalopathyDevelopmental Disabilities +[12] 
Global Approved IndicationsHepatolenticular Degeneration
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved Date1991/01/01
Country/TerritoryCanadaUnited StatesUganda +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesTeva Pharmaceuticals Usa Inc
China Registration ClassN/A

Develop Information

Active CompaniesEton Pharmaceuticals IncRecordati Rare Diseases IncNobelpharma Co Ltd +[5] 
Inactive CompaniesJohns Hopkins UniversityUniversity Of MichiganMakerere University
Active IndicationsHypozincemiaInfantile Epileptic-Dyskinetic EncephalopathyDevelopmental Disabilities +[8] 
Inactive IndicationsHeart FailureCardiomyopathiesCough +[4] 

Other Information

ATC CodeA16AX05
Related LinksWikipediaKEGG